PTGX: Utang jangka cendhak perusahaan Protagonist Therapeutics
High R&D expenditures and peptide patent protection create significant barriers to entry for competitors. The evolution of short-term debt load on the GURU.Markets chart visualizes this process, where the latest value is recorded as 0.00. Primary risks are linked to potential FDA trial failures, while the geopolitical status of the drugs minimizes external pressure on Protagonist Therapeutics (PTGX).
Rincian metrik lan analitis perusahaan Protagonist Corp (PTGX)
- kuotasi saiki lan rata-rata prakiraan nilai:
- informasi kapitalisasi pasar:
- data nilai buku modal saham:
- data utang lan likuiditas:
Total Utang marang Modal Protagonist Therapeutics|PTGX - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Protagonist Therapeutics|PTGX - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Protagonist|PTGX - Kewajiban jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Protagonist Therapeutics|Likuiditas cepet protagonist-inc.com
- indikator pendapatan resik lan kelipatan nilai:
Analisis wiwitan perusahaan:PTGX - Protagonist
The financial stability of Protagonist Therapeutics (PTGX) depends on its ability to service obligations due within one year, which is reflected in the company's short-term liability structure. This indicator aggregates all current debts to assess the risk of cash flow gaps, particularly given the high costs of energy-efficient laboratories and sustainable peptide synthesis, directly impacting the calculation of the fair value of assets.
Analisis pesaing
ARGX - Utang jangka cendhak perusahaan|Silihan lan utang jangka cendhak perusahaan BNTX (BioNTech Inc.)|Abivax (ABVX) - Utang jangka cendhak perusahaan|Kewajiban jangka cendhak perusahaan ADMA Corp|IMVT (Immunovant, Inc.) - Utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan kiniksa.com|Kewajiban jangka cendhak perusahaan GRFS (Grifols)|ADPT (Adaptive Biotech) - Silihan lan utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan CLDX (Celldex)|Gunggunge utang jangka cendhak Aurinia Corp (AUPH)|BCRX - Utang jangka cendhak perusahaan|veratx.com (VERA) - Kewajiban jangka cendhak perusahaan|Dianthus Therapeutics, Inc. (DNTH) - Utang jangka cendhak perusahaan|Kewajiban jangka cendhak perusahaan Pharvaris NV|Kewajiban jangka cendhak perusahaan ABCL|Utang jangka cendhak perusahaan Tourmaline|Utang jangka cendhak perusahaan Precigen, Inc. (PGEN)|pharming.com - Tanggungan utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan NKTR (Nektar Therapeutics Inc.)|Upstream Bio, Inc. (UPB) - Utang jangka cendhak|ZBIO - Utang jangka cendhak perusahaan|Kewajiban jangka cendhak IMNM|Gossamer Bio, Inc. (GOSS) - Utang jangka cendhak perusahaan|kalvista.com - Silihan lan utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan Septerna|Utang jangka cendhak Pieris Pharma PVLA|Kewajiban jangka cendhak perusahaan SVRA (Savara Corp)|Gedhene kewajiban jangka cendhak RIGL|Utang jangka cendhak perusahaan ANAB (AnaptysBio, Inc.)|Utang jangka cendhak perusahaan astriatx.com ATXS|enGene - Utang jangka cendhak perusahaan|Tanggungan jangka cendhak rapt.com (RAPT)|aerovatetx.com (JBIO) - Utang jangka cendhak perusahaan|Utang jangka cendhak Aclaris Therapeutics, Inc (ACRS)|Utang jangka cendhak perusahaan Kyverna Therapeutics|Tanggungan utang jangka cendhak perusahaan TLSA (tizianalifesciences.com)|Utang jangka cendhak perusahaan CABA|Gunggunge utang jangka cendhak Ventyx Biosciences Inc.|Utang jangka cendhak perusahaan Theratechnologies Inc THTX|Gunggunge utang jangka cendhak Avalo Therapeutics Inc (AVTX)|ELDN: Kewajiban jangka cendhak perusahaan|agenusbio.com - Gedhene kewajiban jangka cendhak|CLYM (Climb Bio) - Kewajiban jangka cendhak perusahaan|zurabio.com - Silihan lan utang jangka cendhak perusahaan|Kewajiban jangka cendhak perusahaan ATYR|ADAG (Adagene Corp) - Gedhene kewajiban jangka cendhak|Utang jangka cendhak perusahaan IMA|STTK (shattucklabs.com) - Silihan lan utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan EQ (Equillium)|Connect Biopharma Holdings (CNTB) - Utang jangka cendhak|IMUX - Utang jangka cendhak perusahaan|Silihan lan utang jangka cendhak perusahaan ATRA (Atara Biotherapeutics)|IFRX: Utang jangka cendhak perusahaan|x4pharma.com (XFOR) - Utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan Adicet Bio Inc.|Celularity Corp - Kewajiban jangka cendhak|Utang jangka cendhak perusahaan INMB|BRNS - Utang jangka cendhak|Kezar Life Sciences - Kewajiban jangka cendhak perusahaan|Utang jangka cendhak perusahaan sabbiotherapeutics.com SABS|AKTX: Kewajiban jangka cendhak perusahaan|Enlivex Therapeutics - Gedhene kewajiban jangka cendhak|QTTB: Utang jangka cendhak perusahaan|GOVX - Gunggunge utang jangka cendhak|EDSA (Edesa Biotech, Inc.) - Utang jangka cendhak perusahaan|Kewajiban jangka cendhak perusahaan ibioinc.com (IBIO)|Utang jangka cendhak perusahaan Carisma Therapeutics (CARM)|Gunggunge utang jangka cendhak XTL Biopharmaceuticals Ltd|Utang jangka cendhak perusahaan Bolt Biotherapeutics, Inc. BOLT|HCWB (HCW Biologics, Inc.) - Kewajiban jangka cendhak|APVO: Kewajiban jangka cendhak perusahaan|aimimmuno.com - Gedhene kewajiban jangka cendhak|ADTX: Utang jangka cendhak perusahaan|Tanggungan jangka cendhak GRI Bio Inc GRI|Kewajiban jangka cendhak perusahaan XRTX|Tanggungan utang jangka cendhak perusahaan HIND (Vyome Therapeutics)|Utang jangka cendhak perusahaan Revelation Biosciences (REVB)|INDP: Kewajiban jangka cendhak|Utang jangka cendhak perusahaan SCNI (Scinai Immunotherapeutics Ltd.)|Silihan lan utang jangka cendhak perusahaan CALI|Affimed Therapeutics - Utang jangka cendhak perusahaan|ALLK - Utang jangka cendhak perusahaan|hookipapharma.com (HOOK) - Utang jangka cendhak perusahaan|IGM Biosciences - Silihan lan utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan iTeos Therapeutics, Inc.|Kewajiban jangka cendhak perusahaan Ocean Biomedical Inc (OCEA)|Utang jangka cendhak perusahaan TCBP|Utang jangka cendhak perusahaan Third Harmonic Bio Inc (THRD)